InMed Pharmaceuticals, Inc. (INM)
1.19
-0.10
(-7.75%)
USD |
NASDAQ |
Dec 19, 16:00
1.195
0.00 (0.00%)
Pre-Market: 20:00
InMed Pharmaceuticals Shareholders Equity (Quarterly): 11.59M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 0.0827M |
| Aurinia Pharmaceuticals, Inc. | 365.77M |
| Edesa Biotech, Inc. | 12.45M |
| Lexaria Bioscience Corp. | 2.990M |
| Xenon Pharmaceuticals, Inc. | 559.51M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.36M |
| Total Liabilities (Quarterly) | 1.770M |
| Debt to Equity Ratio | 0.0552 |
| Current Ratio | 6.945 |
| Net Debt Paydown Yield | 1.13% |